>
COMMANDS Global: GP Symbol: IBM FA
↑↓ Navigate Enter Open Esc Close ` Toggle
Articles > WOLF, CADL, TXN, ADI, NTLA showing five-day upward surge

WOLF, CADL, TXN, ADI, NTLA showing five-day upward surge

By KlickAnalytics Data Insights  |   February 20, 2025 10:42AM ET

Wolfspeed, Inc. (WOLF)

WOLF is trading UP for the last 5 days, and it at trading at $7.20 with volume of 7,804,988 and a one day change of $0.26 (3.75%). Wolfspeed, Inc. has a 52-week low of 5.00 and a 52-week high of $30.86. The business's 50-day moving average price is $6.75 and its 200 day moving average price is $14.09. The firm has a market cap of $1 million, a P/E ratio of 0.00, and a beta of 1.43.

For more information on WOLF:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • Candel Therapeutics, Inc. (CADL)

    CADL is trading UP for the last 5 days, and it at trading at $13.27 with volume of 2,496,813 and a one day change of $2.80 (26.70%). Candel Therapeutics, Inc. has a 52-week low of 1.40 and a 52-week high of $14.60. The business's 50-day moving average price is $7.77 and its 200 day moving average price is $6.87. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of -1.25.

    For more information on CADL:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • Texas Instruments Incorporated (TXN)

    TXN is trading UP for the last 5 days, and it at trading at $201.48 with volume of 2,101,818 and a one day change of $5.16 (2.63%). Texas Instruments Incorporated has a 52-week low of 155.03 and a 52-week high of $218.77. The business's 50-day moving average price is $187.24 and its 200 day moving average price is $194.32. The firm has a market cap of $167 million, a P/E ratio of 24.50, and a beta of 0.96.

    For more information on TXN:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • Analog Devices, Inc. (ADI)

    ADI is trading UP for the last 5 days, and it at trading at $245.68 with volume of 1,556,920 and a one day change of $4.02 (1.66%). Analog Devices, Inc. has a 52-week low of 182.22 and a 52-week high of $242.51. The business's 50-day moving average price is $214.49 and its 200 day moving average price is $220.78. The firm has a market cap of $106 million, a P/E ratio of 37.06, and a beta of 1.04.

    For more information on ADI:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • Intellia Therapeutics, Inc. (NTLA)

    NTLA is trading UP for the last 5 days, and it at trading at $12.54 with volume of 1,493,405 and a one day change of $0.26 (2.08%). Intellia Therapeutics, Inc. has a 52-week low of 9.01 and a 52-week high of $34.87. The business's 50-day moving average price is $11.39 and its 200 day moving average price is $18.89. The firm has a market cap of $1 million, a P/E ratio of 0.00, and a beta of 1.80.

    Top news headlines for NTLA

  • CAMBRIDGE, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, will present its fourth quarter and full-year 2024 financial results and operational highlights in a conference call on February 27, 2025, at 8 a.m. ET.
  • NEW YORK, NY / ACCESS Newswire / February 20, 2025 / If you suffered a loss on your Intellia Therapeutics, Inc. (NASDAQ:NTLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/intellia-therapeutics-inc-lawsuit-submission-form?prid=130813&wire=1 or contact Joseph E. Levi, Esq.
  • NEW YORK, NY / ACCESS Newswire / February 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Intellia Therapeutics, Inc. ("Intellia" or "the Company") (NASDAQ:NTLA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Intellia securities between July 30, 2024 and January 8, 2025, both dates inclusive (the "Class Period").
  • NEW YORK , Feb. 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Intellia Therapeutics, Inc. (NASDAQ: NTLA). Shareholders who purchased shares of NTLA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

  • For more information on NTLA:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • This article was generated by KlickAnalytics data insight content engine.

    Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.

    Market News ×
    Loading news…